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background: The incidence of heart failure in hypertrophic cardiomyopathy (HCM) is reported to be low (2-5%). Little is known about demographic 
characteristics and outcomes of heart failure in HCM patients, but women with HCM have been reported to have worse outcomes.
Methods: We compiled all hospitalizations in the Nationwide Inpatient Sample (NIS) in years 2003-2010 with HCM as a diagnosis. We examined 
demographics, clinical characteristics, and hospitalization outcomes amongst those with acute hospitalization for heart failure (CHF).
results: Amongst 31236 admissions, heart failure was the primary diagnosis in 34.8% in patients with HCM. In-hospital mortality improved 
from 7% in 2003 to 4.9% in 2010. Overall, women constituted 71.4 % (7,766) of all cases. Compared to men, women were more likely to be 
hypertensive (58.9% vs. 54.9%, p=<0.0001) and older (74.2 vs. 63.7 years, p=<0.0001). Women were less likely to have atrial fibrillation (41.4% vs. 
48.3%, p=<0.0001), coronary artery disease (36.7% vs. 38.9%, p=0.03), diabetes (21.2% vs. 23.9%, p=0.002) and chronic kidney disease (11.2% 
vs.16.4%, p=<0.0001). Women with CHF had increased in-hospital mortality (5.9%, n=461) than men with CHF (4.8%, n=151) p=0.03. However, 
after adjustment for co morbidities (age, race, hypertension, atrial fibrillation, coronary artery disease, diabetes mellitus, chronic kidney disease), 
women with HCM and CHF did not have increased mortality (OR: 1.07; 0.86-1.35).
conclusion:CHF accounts for a third of all hospitalizations in patients with HCM. Though women constitute nearly three-quarters of these 
admissions, they do not have an increased risk of mortality when adjusted for age and other comorbidities.
